EP2328548A1 - Anti-static skin products and method - Google Patents
Anti-static skin products and methodInfo
- Publication number
- EP2328548A1 EP2328548A1 EP09818132A EP09818132A EP2328548A1 EP 2328548 A1 EP2328548 A1 EP 2328548A1 EP 09818132 A EP09818132 A EP 09818132A EP 09818132 A EP09818132 A EP 09818132A EP 2328548 A1 EP2328548 A1 EP 2328548A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- skin
- conditioning product
- skin softening
- softening
- product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000000034 method Methods 0.000 title description 2
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 29
- 230000003750 conditioning effect Effects 0.000 claims abstract description 26
- 125000002091 cationic group Chemical group 0.000 claims abstract description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 17
- 230000003472 neutralizing effect Effects 0.000 claims abstract description 8
- 239000000203 mixture Substances 0.000 claims description 20
- 238000009472 formulation Methods 0.000 claims description 19
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical group [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 12
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol group Chemical group C(CCCCCCCCCCCCCCC)O BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 claims description 8
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims description 8
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 claims description 8
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 5
- -1 Hydroxypropyl Chemical group 0.000 claims description 5
- 229960000686 benzalkonium chloride Drugs 0.000 claims description 5
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 claims description 5
- 239000003205 fragrance Substances 0.000 claims description 5
- 229960005323 phenoxyethanol Drugs 0.000 claims description 5
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical group CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 4
- 229960000541 cetyl alcohol Drugs 0.000 claims description 4
- WOWHHFRSBJGXCM-UHFFFAOYSA-M cetyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)C WOWHHFRSBJGXCM-UHFFFAOYSA-M 0.000 claims description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 4
- 239000003974 emollient agent Substances 0.000 claims description 4
- 239000003995 emulsifying agent Substances 0.000 claims description 4
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 claims description 4
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 claims description 4
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 claims description 4
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 claims description 4
- 229940075529 glyceryl stearate Drugs 0.000 claims description 4
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 claims description 4
- 229940100460 peg-100 stearate Drugs 0.000 claims description 4
- 239000003755 preservative agent Substances 0.000 claims description 4
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 claims description 4
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 claims description 4
- 229960003415 propylparaben Drugs 0.000 claims description 4
- 239000002562 thickening agent Substances 0.000 claims description 4
- 108010073771 Soybean Proteins Proteins 0.000 claims description 3
- 235000010443 alginic acid Nutrition 0.000 claims description 3
- 229920000615 alginic acid Polymers 0.000 claims description 3
- 230000002421 anti-septic effect Effects 0.000 claims description 3
- 230000002335 preservative effect Effects 0.000 claims description 3
- 229940001941 soy protein Drugs 0.000 claims description 3
- 240000009108 Chlorella vulgaris Species 0.000 claims description 2
- 235000007089 Chlorella vulgaris Nutrition 0.000 claims description 2
- 230000000844 anti-bacterial effect Effects 0.000 claims description 2
- 239000003963 antioxidant agent Substances 0.000 claims description 2
- 230000003078 antioxidant effect Effects 0.000 claims description 2
- 235000012000 cholesterol Nutrition 0.000 claims description 2
- 230000035876 healing Effects 0.000 claims description 2
- CAHGCLMLTWQZNJ-RGEKOYMOSA-N lanosterol Chemical class C([C@]12C)C[C@@H](O)C(C)(C)[C@H]1CCC1=C2CC[C@]2(C)[C@H]([C@H](CCC=C(C)C)C)CC[C@@]21C CAHGCLMLTWQZNJ-RGEKOYMOSA-N 0.000 claims description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims 2
- GQOKIYDTHHZSCJ-UHFFFAOYSA-M dimethyl-bis(prop-2-enyl)azanium;chloride Chemical group [Cl-].C=CC[N+](C)(C)CC=C GQOKIYDTHHZSCJ-UHFFFAOYSA-M 0.000 claims 2
- 235000019270 ammonium chloride Nutrition 0.000 claims 1
- 239000007864 aqueous solution Substances 0.000 claims 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 7
- 230000003020 moisturizing effect Effects 0.000 abstract description 7
- 239000004615 ingredient Substances 0.000 abstract description 6
- 238000002360 preparation method Methods 0.000 abstract description 6
- 239000000654 additive Substances 0.000 abstract description 5
- 239000011148 porous material Substances 0.000 abstract description 5
- 230000000996 additive effect Effects 0.000 abstract description 3
- 239000004909 Moisturizer Substances 0.000 abstract description 2
- 230000001333 moisturizer Effects 0.000 abstract description 2
- 230000002195 synergetic effect Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 25
- 210000004209 hair Anatomy 0.000 description 11
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 4
- 229920000289 Polyquaternium Polymers 0.000 description 4
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 4
- 206010013786 Dry skin Diseases 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 239000010410 layer Substances 0.000 description 3
- 210000004927 skin cell Anatomy 0.000 description 3
- 230000036558 skin tension Effects 0.000 description 3
- 240000004385 Centaurea cyanus Species 0.000 description 2
- 235000005940 Centaurea cyanus Nutrition 0.000 description 2
- 244000236655 Diospyros kaki Species 0.000 description 2
- 244000207620 Euterpe oleracea Species 0.000 description 2
- 235000012601 Euterpe oleracea Nutrition 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 244000294611 Punica granatum Species 0.000 description 2
- 235000014360 Punica granatum Nutrition 0.000 description 2
- 235000010841 Silybum marianum Nutrition 0.000 description 2
- 206010040849 Skin fissures Diseases 0.000 description 2
- 240000002299 Symphytum officinale Species 0.000 description 2
- 235000005865 Symphytum officinale Nutrition 0.000 description 2
- 229940067596 butylparaben Drugs 0.000 description 2
- 229960002788 cetrimonium chloride Drugs 0.000 description 2
- 230000037336 dry skin Effects 0.000 description 2
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 2
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 2
- 229960002216 methylparaben Drugs 0.000 description 2
- UHXJSJAZDZCMGV-UHFFFAOYSA-N (1-hydroxy-3-octadecanoyloxypropan-2-yl) 2-(2,3-dihydroxypropyl)octadecanoate Chemical compound C(C(O)CO)C(C(=O)OC(COC(CCCCCCCCCCCCCCCCC)=O)CO)CCCCCCCCCCCCCCCC UHXJSJAZDZCMGV-UHFFFAOYSA-N 0.000 description 1
- 241000205585 Aquilegia canadensis Species 0.000 description 1
- 235000011511 Diospyros Nutrition 0.000 description 1
- 235000008597 Diospyros kaki Nutrition 0.000 description 1
- 244000178870 Lavandula angustifolia Species 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 240000000513 Santalum album Species 0.000 description 1
- 235000008632 Santalum album Nutrition 0.000 description 1
- 241000320380 Silybum Species 0.000 description 1
- 244000272459 Silybum marianum Species 0.000 description 1
- 244000290333 Vanilla fragrans Species 0.000 description 1
- 235000009499 Vanilla fragrans Nutrition 0.000 description 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
- 230000037374 absorbed through the skin Effects 0.000 description 1
- 235000003650 acai Nutrition 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 229940116224 behenate Drugs 0.000 description 1
- UKMSUNONTOPOIO-UHFFFAOYSA-M behenate Chemical compound CCCCCCCCCCCCCCCCCCCCCC([O-])=O UKMSUNONTOPOIO-UHFFFAOYSA-M 0.000 description 1
- SKKTUOZKZKCGTB-UHFFFAOYSA-N butyl carbamate Chemical compound CCCCOC(N)=O SKKTUOZKZKCGTB-UHFFFAOYSA-N 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229940069826 chlorella vulgaris extract Drugs 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- SOROIESOUPGGFO-UHFFFAOYSA-N diazolidinylurea Chemical compound OCNC(=O)N(CO)C1N(CO)C(=O)N(CO)C1=O SOROIESOUPGGFO-UHFFFAOYSA-N 0.000 description 1
- 229960001083 diazolidinylurea Drugs 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940083325 echinacea angustifolia leaf extract Drugs 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 230000001846 repelling effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 description 1
- 239000002569 water oil cream Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/731—Cellulose; Quaternized cellulose derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
- A61K8/416—Quaternary ammonium compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/817—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions or derivatives of such polymers, e.g. vinylimidazol, vinylcaprolactame, allylamines (Polyquaternium 6)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/54—Polymers characterized by specific structures/properties
- A61K2800/542—Polymers characterized by specific structures/properties characterized by the charge
- A61K2800/5426—Polymers characterized by specific structures/properties characterized by the charge cationic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/594—Mixtures of polymers
Definitions
- the Present Invention relates to the field of protective compositions to condition dry, cracked, and chapped skin so as to retain moisture, and to condition hair.
- BACKGROUND OF THE INVENTION There is currently a wide variety of moisturizing skin softeners on the market. The primary purpose of such products is to prevent moisture from escaping from the skin while adding moisture to the skin.
- the vast majority of these commercial products are oil based, or they utilize an oil-water emulsion.
- the effect of these oil based products is to coat the skin with a layer that is water impermeable. This water impermeable layer prevents the skin from losing water due to evaporation.
- Most of these preparations use various additives that treat skin to make it smooth, moist, and supple.
- the Present Invention is an aqueous preparation that comprises cationic agents to neutralize a negative charge thereby relieving tension in the skin, allowing the pores to close, and preventing moisture from escaping. It reduces the distance between the pores.
- the difference between the Present Invention and other water based skin conditioners is the amount of cationic agents used.
- the Present Invention utilizes much more of these ingredients than other commercial products. This produces the unexpected result of neutralizing the charge on the skin and relieving tension.
- a typical formulation of the product of the Present Invention might consist of: Celquat SC-240c (Polyquaternium-10) 0-4% Merquat l OO 0-11 % as the principal ingredients (cationic agents) and: • Distilled Water • Propylene Glycol • Tetrasodium EDTA • Polywax • Glycerol Monostearate (Glyceryl Stearate) • Vanilla • Glycerin • Germall Plus (Diazolidinyl Urea & lsopropynyl Butylcarbamate) This formulation is typical.
- Merquat 280 is Polyquaternium-22. Celquat and Merquat are both strong cationic agents. The formulations created thus far comprised both Celquat and Merquat. However, it could be useful to have either agent be the sole active ingredient. Cationic agents other than Celquat and Merquat are known in the art. These other agents are also useful in the Present Invention either as a substitute for Celquat and Merquat or as an additive. As mentioned before, only water based products can utilize cationic agents. The difference between the Present Invention and other commercial conditioners is the strength of the cationic effect. This produces the unexpected result of neutralizing the negative charge of the skin, thereby reducing skin tension (by allowing the skin cells to reside closer to each other), and closing pores so as to retain moisture.
- the basic formulation mainly comprises the cationic agents in an aqueous base.
- moisturizing and conditioning agents can be added to the basic formulation.
- the basic formulation may be added to other water based skin conditioners to enhance their effect.
- the Present Invention may be used as a treatment for psoriasis which is aggravated by dry skin. It may also be used to treat chafed elbows.
- hair conditioners it enhances the plasticizing effect by neutralizing any negative charge retained by the hair.
- Other formulations comprise the following ingredients: • Water
- formulations comprise:
- some embodiments comprise an antiseptic, an anti-inflammatory agent, an antioxidant, an astringent, and an agent to promote skin healing, having cleansing, antibacterial and antiseptic attributes.
- a fragrance would probably be added.
- the quaternary conditioners that are used include (at least one must be used), without limitation: • Polyquaternium-22; • Polyquaternium-67; • Cetyl Trimethyl Ammonium Chloride; • Hydroxypropyl Thmonium Hydrolyzed Soy Protein; and • Benzalkonium Chloride.
- the preservatives used include, without limitation: • Phenoxyethanol. • Methyloaraben, • Butylparben, • Ethylparaben, • Propylparaben, • Isobutylpareben, and • Phenoxyethanol.
- the thickeners used include, without limitation, Cetyl Alcohol, and Stearyl Alcohol.
- the emollients used include, without limitation:
- the emulsifiers used include, without limitation, Glyceryl Stearate, and PEG-100 Stearate.
- the neutralizing agent used was a 5% solution of sodium hydroxide. Fragrances used were lavender, sandalwood, and honeysuckle.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10201108P | 2008-10-02 | 2008-10-02 | |
| PCT/US2009/045881 WO2010039291A1 (en) | 2008-10-02 | 2009-06-01 | Anti-static skin products and method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP2328548A1 true EP2328548A1 (en) | 2011-06-08 |
Family
ID=42073794
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP09818132A Withdrawn EP2328548A1 (en) | 2008-10-02 | 2009-06-01 | Anti-static skin products and method |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP2328548A1 (enExample) |
| JP (1) | JP2012504616A (enExample) |
| CN (1) | CN102065832B (enExample) |
| AU (1) | AU2009300281B2 (enExample) |
| CA (1) | CA2726236A1 (enExample) |
| WO (1) | WO2010039291A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9232790B2 (en) * | 2011-08-02 | 2016-01-12 | Kimberly-Clark Worldwide, Inc. | Antimicrobial cleansing compositions |
| US8877259B2 (en) | 2012-02-09 | 2014-11-04 | Mary Kay Inc. | Cosmetic formulation |
| DE102012010206A1 (de) * | 2012-05-15 | 2013-11-21 | Koray Kaynak | Alkoholfreies 'Kölnisch Wasser'-Ersatzprodukt |
| US9265714B2 (en) | 2013-09-26 | 2016-02-23 | Colgate-Palmolive Company | Cleansing composition comprising a cationic and nonionic surfactant mixture |
| GB2541318B (en) | 2014-04-30 | 2021-05-12 | Kimberly Clark Co | Non-therapeutic methods for increasing adipogenesis or lipogenesis using an Undaria extract |
| BR112016023653B1 (pt) | 2014-04-30 | 2020-12-08 | Kimberly-Clark Worldwide, Inc | composição tópica |
| MX2016013135A (es) | 2014-04-30 | 2017-01-20 | Kimberly Clark Co | Composiciones y metodos para reducir el estres oxidativo. |
| KR20200122411A (ko) | 2014-04-30 | 2020-10-27 | 킴벌리-클라크 월드와이드, 인크. | 피부 노화의 징후를 감소시키는 방법 |
| EP3466401A1 (en) * | 2017-10-06 | 2019-04-10 | Coty, Inc. | Hair styling method and kit thereof |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5635469A (en) * | 1993-06-10 | 1997-06-03 | The Procter & Gamble Company | Foaming cleansing products |
| US6844005B2 (en) * | 2002-02-25 | 2005-01-18 | Trutek Corp | Electrostatically charged nasal application product with increased strength |
| KR100481563B1 (ko) * | 1997-09-12 | 2005-04-08 | 더 프록터 앤드 갬블 캄파니 | 피부 또는 모발용 세정 및 컨디셔닝 제품 |
| CA2362349A1 (en) * | 1999-02-19 | 2000-08-24 | The Procter & Gamble Company | Leave-on cosmetic compositions containing a cationic polymer |
| GB9903925D0 (en) * | 1999-02-19 | 1999-04-14 | Procter & Gamble | Cosmetic compositions |
| US6562368B2 (en) * | 1999-12-16 | 2003-05-13 | Dermatrends, Inc. | Transdermal administration of oxybutynin using hydroxide-releasing agents as permeation enhancers |
| JP2003528045A (ja) * | 1999-12-16 | 2003-09-24 | ダーマトレンズ， インコーポレイテッド | フェニルプロパノールアミンの経皮投与 |
| JP2006045081A (ja) * | 2004-08-02 | 2006-02-16 | Pola Chem Ind Inc | 皮膚外用剤 |
| US20060034792A1 (en) * | 2004-08-11 | 2006-02-16 | L'oreal | Cosmetic composition based on a cationic surfactant, an amino silicone or vinyl silicone, a fatty alcohol and a propellant |
| FR2874175B1 (fr) * | 2004-08-11 | 2006-11-24 | Oreal | Composition cosmetique a base d'un tensioactif cationique, d'une silicone aminee ou vinylique, d'un alcool gras et d'un agent propulseur |
| JP5022568B2 (ja) * | 2005-02-10 | 2012-09-12 | ポーラ化成工業株式会社 | エッセンス剤形の皮膚外用剤 |
| BRPI0621714A2 (pt) * | 2006-06-02 | 2011-12-20 | Univ Columbia | composições contendo sais de zinco para revestir artigos médicos |
| JP5107560B2 (ja) * | 2006-11-22 | 2012-12-26 | 日本精化株式会社 | シクロヘキサンジカルボン酸ジエステル及びこれを含有する化粧料又は皮膚外用剤 |
-
2009
- 2009-06-01 WO PCT/US2009/045881 patent/WO2010039291A1/en not_active Ceased
- 2009-06-01 CN CN200980122433.1A patent/CN102065832B/zh not_active Expired - Fee Related
- 2009-06-01 AU AU2009300281A patent/AU2009300281B2/en not_active Ceased
- 2009-06-01 JP JP2011530076A patent/JP2012504616A/ja active Pending
- 2009-06-01 EP EP09818132A patent/EP2328548A1/en not_active Withdrawn
- 2009-06-01 CA CA2726236A patent/CA2726236A1/en not_active Abandoned
Non-Patent Citations (1)
| Title |
|---|
| See references of WO2010039291A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2012504616A (ja) | 2012-02-23 |
| CN102065832B (zh) | 2013-03-27 |
| AU2009300281A1 (en) | 2010-04-08 |
| CN102065832A (zh) | 2011-05-18 |
| CA2726236A1 (en) | 2010-04-08 |
| WO2010039291A1 (en) | 2010-04-08 |
| AU2009300281B2 (en) | 2013-09-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2009300281B2 (en) | Anti-static skin products and method | |
| US6579516B1 (en) | Methods of delivering materials into the skin, and compositions used therein | |
| US6120782A (en) | Methods of delivering materials into the skin, and compositions used therein | |
| US6878378B1 (en) | External skin care composition | |
| US20090246163A1 (en) | Anti-static skin products and method | |
| JP4133837B2 (ja) | 皮膚保湿用ゲルおよび方法 | |
| EP2029089B1 (de) | O/w emulsion zur pflege der hand | |
| JP2002193755A (ja) | フケ・カユミ防止頭髪用および洗髪用化粧料 | |
| KR20210111230A (ko) | 폴리글리세린-3을 함유하는 항균 또는 보존용 조성물 | |
| NL2035478B1 (en) | Cosmetic formulation | |
| JP3479048B2 (ja) | 化粧料及び不織布含浸化粧料 | |
| EP3226827B1 (en) | Aluminium-free antiperspirant/deodorant compositions and method of preparing the same | |
| JP2005206539A (ja) | 頭皮頭髪化粧料 | |
| AU2007200216A1 (en) | Skin formulation usable as a therapeutic application for the treatment of general skin disorders and a method of preparation thereof | |
| TW201315487A (zh) | 延長皮膚保濕期間組合物 | |
| JP2008273905A (ja) | 毛髪化粧料 | |
| EP3471696A1 (en) | Hand sanitizing composition | |
| JP2003063943A (ja) | 皮膚外用剤 | |
| KR20190045684A (ko) | 미세먼지 방진 조성물 | |
| KR20130090613A (ko) | 인삼줄기 추출물을 함유하는 모발 및 두피 상태 개선용 조성물 | |
| DE102014209988A1 (de) | Aluminiumlactat als Hautschutzkomponente |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20110204 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR |
|
| AX | Request for extension of the european patent |
Extension state: AL BA RS |
|
| DAX | Request for extension of the european patent (deleted) | ||
| RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: WAHI, ASHOK |
|
| RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: TRUTEK CORP. |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20150106 |